Asymptomatic detection of SARS-CoV-2 among cancer patients receiving infusional anti-cancer therapy.
Justin ShayaAngelo CabalTaylor NonatoFrancesca TorrianiJoseph CalifanoScott LippmanAssuntina SaccoRana R McKayPublished in: Cancer medicine (2021)
Overall, among a cohort of active cancer patients receiving anti-cancer therapy, an asymptomatic SARS-CoV2 PCR-based screening protocol detected a small cohort of asymptomatic carriers. The majority of these patients remained asymptomatic on long-term follow-up and outcomes were much more favorable compared to previously described outcomes of cancer patients with symptomatic COVID-19 infection.
Keyphrases
- sars cov
- cancer therapy
- papillary thyroid
- squamous cell
- drug delivery
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- lymph node metastasis
- type diabetes
- squamous cell carcinoma
- prognostic factors
- adipose tissue
- metabolic syndrome
- insulin resistance
- coronavirus disease
- patient reported
- glycemic control
- label free